Hexo Corp. has a plan to become profitable, but getting there will require an influx of newly-licensed pot shops to open in Canada's biggest consumer markets, the company's chief executive officer said Thursday. 

"Our plan to achieve adjusted positive EBITDA by the end of the calendar year will depend on the growth of retail stores in our two largest markets, Ontario and Quebec," said Sebastien St-Louis in a conference call with analysts.

"We need the governments to either continue to build out the retail infrastructure, or allow the private sector to provide the service that consumers demand."

In December, New Brunswick-based producer Zenabis recalled a line of “CBD Light” gel caps, labelled as containing six milligrams of CBD per capsule, with no THC. It turns out, they were actually THC gel caps with no CBD whatsoever. 

Zenabis isn’t the only producer to run into labelling issues. Last September, Aurora Cannabis recalled it’s Blue Dream Sativa which had been sold through the Société québécoise du cannabis (SQDC). The label said the flower contained 19.1 per cent total THC, but the correct value was 15.7 per cent. More than 3,000 units were sold before the product was recalled. 

Montrealers can expect same-day delivery of

The recent filing for Canadian bankruptcy by cannabis company Green Growth Brands is perhaps another sign that U.S-based multistate operators are looking north for potential solutions amid increasing distress in the industry.

While such protection remains out of reach in the U.S. because of marijuana’s federal illegality, Canadian law is an option to explore even as it remains unclear exactly what avenues are available.

Green Growth’s move appears to be based on the reality of its parent company being an Ontario-based entity even as the company’s assets are largely licensed in the U.S.

Global cannabis sales are expected to surge 38% to $20.4 billion this year despite the coronavirus-induced recession, according to new research from Arcview Group. 

The market research company released the 8th edition of its The State of Legal Cannabis Markets report this week, which also predicted sales will climb to a whopping $46.8 billion in 2025. 

Other highlights from the report include insights and statistics on both new and established legal cannabis markets in the U.S.

When management at CannTrust announced on May 29 that a suspended

The months of May and June have already shown a great amount of positive gains for many leading marijuana stocks. As we continue to traverse into the summer, it looks like these cannabis stock gains are becoming more and more consistent. There are several reasons as to why the cannabis industry is showing so much upward propensity right now. For one, the cannabis industry has recorded more percentage gains and on a more consistent basis than most other areas of the stock market.

To say 2020 could be a defining year for vertically integrated cannabis companies is an understatement.

It will be. And those driving execution in this complex, regulated industry with an enterprise-level solution will prove to be the leaders. 

This year, the cannabis industry has been thrust into yet another transitional period. Legalization legislation is potentially off the table for the foreseeable future, and many are dealing with a shrinking economy for the first time.